Cure My Disease

Don't miss your cure!

 Log in / Sign up

Liver risk under microscope: TURALIO study seeks answers

NCT ID NCT04635111

Recruiting now Knowledge-focused Sponsor: Daiichi Sankyo Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows up to 30 adults with tenosynovial giant cell tumor (TGCT) who had liver test abnormalities while taking TURALIO. The goal is to track long-term liver failure risk and understand how the drug may cause liver injury. Participants will be monitored after stopping TURALIO, and some may provide optional liver biopsies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATOTOXICITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

drug-induced liver injury Giant Cell Tumor of Tendon Sheath tenosynovial giant cell tumor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEPATOTOXICITY TENOSYNOVIAL GIANT CELL TUMOR

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Dana-Farber Cancer Institute

    RECRUITING

    Boston, Massachusetts, 02215, United States

  • Kamalesh K Sankhala MD INC

    RECRUITING

    Santa Monica, California, 90403, United States

  • Kelsey Seybold Clinic - Pearland

    NOT_YET_RECRUITING

    Houston, Texas, 77014, United States

  • Montefiore Medical Center

    WITHDRAWN

    New York, New York, 10467, United States

  • OSU - James Comprehensive Cancer Center

    RECRUITING

    Columbus, Ohio, 43210, United States

  • Sarcoma Oncology Research Center LLC

    NOT_YET_RECRUITING

    Santa Monica, California, 90403, United States

  • The Oncology Institute of Hope and Innovation

    WITHDRAWN

    Whittier, California, 90602, United States

  • UCLA Hematology and Oncology

    RECRUITING

    Santa Monica, California, 90404, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.